NCT01466244已完成不适用
PTEN Determination in Squamous Cell Cancer of The Head and Neck Treated on E5397, A Randomized Phase III Trial of Cisplatin Plus Placebo Versus Cisplatin Plus C225 (Cetuximab) in Metastatic/Recurrent Head and Neck Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 42
- 主要终点
- Cetuximab activity as reflected in RR
研究概览
简要总结
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors predict how well patients will respond to treatment.
PURPOSE: This research study is studying biomarkers in patients with metastatic or recurrent head and neck cancer treated with cisplatin and cetuximab on ECOG-E5397.
详细描述
OBJECTIVES:
Primary
- Compare cetuximab activity, as reflected in response rate (RR), in PTEN-deficient and PTEN-expressing cancers.
Secondary
- Examine RR, progression-free survival (PFS), and overall survival (OS) in PTEN-deficient and PTEN-expressing cancers, by treatment arm.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 120 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Cetuximab activity as reflected in RR
时间窗: 1 year
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
DNA Analysis of Tissue Samples From Patients With Head and Neck CancerHead and Neck CancerNCT00898664Vanderbilt-Ingram Cancer Center74
已完成
不适用
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313Breast CancerNCT00949013SWOG Cancer Research Network1,600
Unknown
不适用
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node BiopsyMelanoma (Skin)NCT00897481Leeds Cancer Centre at St. James's University Hospital1,000
Unknown
不适用
Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 TrialBreast CancerNCT01424865NSABP Foundation Inc1,874
已完成
不适用
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301Head and Neck CancerNCT01487733Eastern Cooperative Oncology Group155
